UK’s Early Value Assessment Pilot Is ‘Catalyst’ For Wider Change - NICE

NICE’s early value assessment (EVA) pilot for medtech will have failed unless it changes the way that medical devices “as a whole” are evaluated in the UK, according to Mark Chapman, the organization’s interim director of medical technology.